top of page
_DSF9432.jpg

Follow our progress

PRESS RELEASES

Sania Therapeutics to present at the American Society of Gene & Cell Therapy Annual Meeting

Read more about our poster details and how to meet with us.

11 April 2024

Sania Therapeutics launches to advance novel medicines for neural circuit dysfunction

Read more about how Sania emerged out of stealth to launch our core technology platforms.

17 May 2023

IN PRESS

Sania targets neural circuit dysfunction with R-scan, Neu-scan

Read more about how Sania selectively targets neural circuits to deliver transformative therapeutics.

Nuala Moran, BioWorld, 17 May 2023

PRESENTATIONS

Generating human-evolved, cell-type-specific AAV capsids for targeted gene delivery

American Society for Gene & Cell Therapy (ASGCT), 08 May 2024

Titratable control of neuronal activity using precision genetic neuromodulation

American Society for Gene & Cell Therapy (ASGCT), 10 May 2024

A low dose, targeted, and controllable gene therapy for the treatment of spasticity

American Society for Gene & Cell Therapy (ASGCT), 09 May 2024

bottom of page